A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Bakar, Osama Bin Abu
Altri autori:	Yasmin, Hasina
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Alzheimer’s disease Neurological disorder Dementia FAERS database FDA adverse event reporting system Rhabdomyolysis Alzheimer's disease > Therapy Nervous System Diseases
Accesso online:	http://hdl.handle.net/10361/23186

Documenti analoghi

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
di: Karmaker, Swastika
Pubblicazione: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
di: Mahee, Sadique Abdal
Pubblicazione: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
di: Jahan, Nusrat
Pubblicazione: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
di: Shehab, Habibul Mohsin
Pubblicazione: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

Role of circular RNA in neurological disease
di: Salsabil, Labiba
Pubblicazione: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
di: Dey, Manashi
Pubblicazione: (2024)

Potential treatments for epigenetic dysregulation in neurological diseases
di: Zaman, Rubaiyat
Pubblicazione: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
di: Chowdhury, Sariya Uzrat
Pubblicazione: (2022)

Emerging therapies of Alzheimer’s disease: a comprehensive review
di: Tasin, Md Abtahi
Pubblicazione: (2023)

Gene editing for neurodegenerative diseases-A review
di: Sharna, Anika Islam
Pubblicazione: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
di: Tasneem, Sadia
Pubblicazione: (2021)

Role of protein’s and future treatment options for Alzheimer’s Disease
di: Islam, Md. Irfath
Pubblicazione: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
di: Saha, Bithi Rani
Pubblicazione: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
di: Tamanna, Mst. Taskia
Pubblicazione: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
di: Hassan, Md. Muhtaz
Pubblicazione: (2020)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
di: Mostofa, Golam
Pubblicazione: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
di: Aana, Afsara Sumon
Pubblicazione: (2021)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
di: Aziz, Farhin
Pubblicazione: (2019)

Alzheimer's disease and marriage : an intimate account /
di: Wright, Lore K.
Pubblicazione: (1993)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

A review on optogenetics and its potential in neurological disorder management
di: Armin, Fariza
Pubblicazione: (2024)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
di: Afra, Sumaiya
Pubblicazione: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
di: Halim, Rabea
Pubblicazione: (2022)

Exploring Alzheimer's disease prediction with XAI in various neural network models
di: Rahman, Quazi Ashikur, et al.
Pubblicazione: (2022)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
di: Mithila, Sabekun Nahar
Pubblicazione: (2023)

Marine compounds in the treatment of Alzheimer’s disease
di: Parveen, Sanjana
Pubblicazione: (2022)

Skeleton /
di: Parkin, Peter

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
di: Khandker, Tahia Anjum
Pubblicazione: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
di: Islam, Md. Rakibul
Pubblicazione: (2023)

An ambient assisted living system for Alzheimer’s patients
di: Abedin, Minhajul, et al.
Pubblicazione: (2023)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
di: Key, Nasrin Sultana
Pubblicazione: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
di: Onanna, Kazi
Pubblicazione: (2024)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
di: Rahman, Towsifur
Pubblicazione: (2024)

A review on adult neurogenesis in Alzheimer’s disease
di: Akter, Moriam
Pubblicazione: (2022)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
di: Roy, Aditya, et al.
Pubblicazione: (2023)

Status of cognitive decline in post covid-19 Bangladeshi patients
di: Bapan, Pranta Saha
Pubblicazione: (2024)

The illness narratives : suffering, healing, and the human condition /
di: Kleinman, Arthur
Pubblicazione: (1988)